NRIX vs SHW · rev $15.3M vs P/E 29, rev $12.46B
Nurix Therapeutics Inc (NRIX) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
NRIX currently screens at market cap $1.77B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the NRIX and SHW stock pages for the full models.
Not investment advice.